Bearish MACD

The chart shows biotech XBI, struggling at resistance (blue line).
At the same time, we have a bearish divergence on MACD.
Taking a look at the components of XBI, link here, seven of those in the top ten, have no P/E at all (not advice, not a recommendation).
What could go wrong?
Stay Tuned
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.
The Danger Point®, trade mark: No. 6,505,279
Pingback: Biotech … Reversal to Wedge « The Danger Point®